×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ZBIO – zenas biopharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ZBIO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/30
06:21 am
zbio
Zenas BioPharma (ZBIO) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Medium
Report
Zenas BioPharma (ZBIO) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
3/29
01:33 am
zbio
Zenas BioPharma Funding Shifts Focus From Survival Risk To Execution Risk [Yahoo! Finance]
Medium
Report
Zenas BioPharma Funding Shifts Focus From Survival Risk To Execution Risk [Yahoo! Finance]
3/27
12:12 am
zbio
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million
Medium
Report
Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million
3/26
04:01 pm
zbio
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock
High
Report
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock
3/21
02:38 pm
zbio
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch [Yahoo! Finance]
Medium
Report
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch [Yahoo! Finance]
3/21
01:31 am
zbio
Zenas BioPharma (ZBIO) was downgraded by Wall Street Zen from "hold"
Medium
Report
Zenas BioPharma (ZBIO) was downgraded by Wall Street Zen from "hold"
3/19
06:20 am
zbio
Zenas BioPharma (ZBIO) was downgraded by Zacks Research from "hold" to "strong sell".
Low
Report
Zenas BioPharma (ZBIO) was downgraded by Zacks Research from "hold" to "strong sell".
3/17
12:30 pm
zbio
Zenas BioPharma (ZBIO) had its price target lowered by Citigroup Inc. from $43.00 to $41.00. They now have a "buy" rating on the stock.
Low
Report
Zenas BioPharma (ZBIO) had its price target lowered by Citigroup Inc. from $43.00 to $41.00. They now have a "buy" rating on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/2
05:44 pm
zbio
Form SCHEDULE 13D/A Zenas BioPharma, Inc. Filed by: MOULDER LEON O JR
Low
Report
Form SCHEDULE 13D/A Zenas BioPharma, Inc. Filed by: MOULDER LEON O JR
4/2
05:02 pm
zbio
Form 4 Zenas BioPharma, Inc. For: Mar 31 Filed by: Lu Hongbo
Low
Report
Form 4 Zenas BioPharma, Inc. For: Mar 31 Filed by: Lu Hongbo
4/1
04:31 pm
zbio
Form 4 Zenas BioPharma, Inc. For: Mar 31 Filed by: Fairmount Funds Management LLC
Medium
Report
Form 4 Zenas BioPharma, Inc. For: Mar 31 Filed by: Fairmount Funds Management LLC
3/31
08:14 pm
zbio
Form 4 Zenas BioPharma, Inc. For: Mar 30 Filed by: MOULDER LEON O JR
Medium
Report
Form 4 Zenas BioPharma, Inc. For: Mar 30 Filed by: MOULDER LEON O JR
3/31
05:00 pm
zbio
Form 4 Zenas BioPharma, Inc. For: Mar 31 Filed by: Lu Hongbo
Low
Report
Form 4 Zenas BioPharma, Inc. For: Mar 31 Filed by: Lu Hongbo
3/31
04:36 pm
zbio
Form 8-K Zenas BioPharma, Inc. For: Mar 26
Medium
Report
Form 8-K Zenas BioPharma, Inc. For: Mar 26
3/30
09:20 am
zbio
Form 424B5 Zenas BioPharma, Inc.
Low
Report
Form 424B5 Zenas BioPharma, Inc.
3/30
09:19 am
zbio
Form 424B5 Zenas BioPharma, Inc.
Low
Report
Form 424B5 Zenas BioPharma, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: